ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Proteinkinase C Epsilon Contributes to Impairment of Renal Blood Flow and Inflammation in Renal Ischemia Reperfusion Injury (IRI)

N. Rüskamp, D. Walacides, R. Song, K. Hüper, M. Mengel, M. Meier, D. Wacker, M. Schiffer, H. Haller, F. Gueler

Nephrology, Medical School Hannover, Hannover, Germany
Radiology, Medical School Hannover, Hannover, Germany
Applied Genomics Center, University of Alberta, Edmonton, Canada

Meeting: 2013 American Transplant Congress

Abstract number: D1573

Background – Proteinkinase C (PKC) isoforms are invovled in several signaling pathways contributing to ischemia reperfusion injury (IRI) and acute transplant rejection. Here we investigated PKC-e knock out mice in a clinically relavant model of hypoxia induced IRI leading acute renal failure with impairment of renal blood flow (RBF) and edema formation in wildtype mice.

Methods – IRI was induced by transient clamping of the renal pedicle for 35 min. Functional contrast free MRI was performed at d1 and d7 to measure renal blood flow (RBF), edema formation and cell infiltration. Histologically, acute tubular necrosis (ATN) and inflammatory cell infiltration (GR-1 and F4/80 positive cells) were investigated. TNF-alpha expression was examined by qPCR and immunohistochemistry.

Results – PKC-e knock out mice had significantly better survival and less s-creatinine elevation than WT mice. By MRI techniques IRI induced renal perfusion impairment was markedly reduced in PKC-e knock out mice compared to WT mice. Acute tubular necrosis (ATN) and inflammatory cell infiltration with Gr-1 pos cells was significantly reduced in the PKC-e knock out mice. qPCR and immunohistochemistry showed reduced up-regulation of TNF-a in PKC-e deficient mice.

Conclusion – Our study proves that PKC-e deficiency attenuated renal IRI by blocking TNF-a up-regulation and attenuating renal blood flow.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Rüskamp N, Walacides D, Song R, Hüper K, Mengel M, Meier M, Wacker D, Schiffer M, Haller H, Gueler F. Proteinkinase C Epsilon Contributes to Impairment of Renal Blood Flow and Inflammation in Renal Ischemia Reperfusion Injury (IRI) [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/proteinkinase-c-epsilon-contributes-to-impairment-of-renal-blood-flow-and-inflammation-in-renal-ischemia-reperfusion-injury-iri/. Accessed May 14, 2025.

« Back to 2013 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences